The collateral source rule is grounded in the idea that a wrongdoer should not benefit from the plaintiff's own foresight in purchasing insurance or from the generosity of a third party who helped cover the plaintiff's losses. The defendant's responsibility is generally measured by the harm it caused, not by whether the plaintiff had a separate safety net.

This keeps the jury's focus on the defendant's actual liability and the full extent of the plaintiff's losses, rather than on how those losses happened to be covered in the meantime.

Under the traditional version of the rule, evidence that a plaintiff received payments from a collateral source, such as health insurance, is generally kept from the jury. The jury is asked to determine the full value of the plaintiff's damages without factoring in outside payments.

Any reimbursement obligations the plaintiff may owe to an insurer or other collateral source, through subrogation or a lien, are typically handled separately after the verdict or settlement, rather than being resolved by the jury itself.

Many states have modified the traditional collateral source rule through legislative reforms, particularly in areas like medical malpractice. Some allow evidence of collateral payments to be introduced, or permit a judge to reduce a verdict to account for them, in ways that differ substantially from state to state.

Because of this variation, whether and how the collateral source rule applies can meaningfully affect both trial strategy and the ultimate size of a damages award depending on where a case is filed.

Even where the collateral source rule protects a plaintiff from having a jury reduce damages based on insurance payments, that protection does not eliminate a separate right the collateral source may have to be reimbursed from the recovery.

In practice, this means a plaintiff can recover full damages at trial while still owing money back to an insurer or other source through a subrogation claim or lien resolved outside the jury's verdict.